Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...
Robust revenue growthStrengthened momentum across all business segments Fourth quarter and full year operating highlights: Three months ended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback